glp-1 trends Receptor Agonist Market Size Monitoring Report: GLP-1 RA Prescribing

These medications, when used correctly with proper medical supervision and lifestyle modifications, can be genuinely life-changing

It typically results from inadequate insulin secretion because of dysfunction of the insulin-secreting pancreatic beta cells

Contraindications and cautions include: Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (absolute contraindication) History of pancreatitis (relative contraindication

Cardiovascular and renal benefits of novel diabetes drugs by baseline cardiovascular risk: a systematic review, meta-analysis, and meta-regression

In recent years, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as cornerstone therapies in the management of T2D and obesity [5,6,7]